These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6111018)

  • 21. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA; Clutter WE; Skor D; Shah SD; Gingerich RP; Parvin CA; Cryer PE
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic interactions of glucagon and cortisol in man--studies with somatostatin.
    Gill A; Johnston DG; Orskov H; Batstone GF; Alberti KG
    Metabolism; 1982 Apr; 31(4):305-11. PubMed ID: 6123061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon does not increase plasma free fatty acid and glycerol concentrations in patients with noninsulin-dependent diabetes mellitus.
    Jeng CY; Sheu WH; Jaspan JB; Polonsky KS; Chen YD; Reaven GM
    J Clin Endocrinol Metab; 1993 Jul; 77(1):6-10. PubMed ID: 8100832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
    Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
    N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State of metabolic control determines role of epinephrine-glucagon interaction in glucoregulation in diabetes.
    Kemmer FW; Lickley HL; Gray DE; Perez G; Vranic M
    Am J Physiol; 1982 Jun; 242(6):E428-36. PubMed ID: 6124126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyrotropin-releasing hormone increases plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J
    Horm Metab Res; 1981 Jul; 13(7):371-5. PubMed ID: 6792023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose and insulin suppression of plasma free fatty acids in obese subjects with normal glucose tolerance or mild, newly diagnosed type 2 (non-insulin-dependent) diabetes.
    Zancanaro C; Cigolini M; Bonora E; Moghetti P; Querena M; Muggeo M
    J Endocrinol Invest; 1990 Jan; 13(1):55-9. PubMed ID: 1969430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of glucagon and free fatty acids with insulin in control of glucose metabolism.
    Chambrier C; Picard S; Vidal H; Cohen R; Riou JP; Beylot M
    Metabolism; 1990 Sep; 39(9):976-84. PubMed ID: 1975421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determinants of glucose and ketoacid concentrations in acutely hyperglycemic diabetic patients.
    Malchoff CD; Pohl SL; Kaiser DL; Carey RM
    Am J Med; 1984 Aug; 77(2):275-85. PubMed ID: 6431813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acetylsalicylic acid on plasma glucose, free fatty acid, betahydroxybutyrate, glucagon and C-peptide responses to salbutamol in insulin-dependent diabetic subjects.
    Giugliano D; Passariello N; Torella R; Cerciello T; Varricchio M; Sgambato S
    Acta Diabetol Lat; 1981; 18(1):27-36. PubMed ID: 7211088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man.
    Busch-Sørensen M; Holst JJ; Lyngsøe J
    J Endocrinol Invest; 1991 Jan; 14(1):25-30. PubMed ID: 1675225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucose metabolism during exercise in man: the role of insulin in the regulation of glucose utilization.
    Lavoie C; Ducros F; Bourque J; Langelier H; Chiasson JL
    Can J Physiol Pharmacol; 1997 Jan; 75(1):36-43. PubMed ID: 9101063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients.
    Tsai AC; Vinik AI; Lasichak A; Lo GS
    Am J Clin Nutr; 1987 Mar; 45(3):596-601. PubMed ID: 2881482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of alpha-and beta-adrenergic inhibition and somatostatin on plasma glucose, free fatty acids, insulin glucagon and growth hormone responses to prostaglandin E1 in man.
    Giugliano D; Torella R; Sgambato S; D'Onofrio F
    J Clin Endocrinol Metab; 1979 Feb; 48(2):302-8. PubMed ID: 429484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.